Dr. Julie Gastier-Foster has more than 20 years' experience directing a clinical genetics laboratory. She believes that high quality laboratory testing is critical to optimal patient diagnosis, care, and outcomes.
Dr. Gastier-Foster's role as the Director of Laboratory and Pathology for Global Hematology/Oncology Pediatric Excellence (HOPE) is to use her experience in clinical laboratory testing, centralized testing for the Children's Oncology group trials, biorepositories, and large cancer sequencing projects to help build infrastructure for better pediatric cancer care in Africa.
Dr. Gastier-Foster has been an integral part of the Children's Oncology Group disease committees for nearly two decades. She has participated in the development and review of protocols, conversion of new biomarkers into clinical trials, and translational research related to prognostic factors. She will utilize this expertise to support efforts to build African pediatric oncology networks. She is an invited member of several grant review committees, permanent and ad hoc, related to her work in cancer biomarkers and biorepository best practices.
American Board of Medical Genetics and Genomics (ABMGG), Clinical Medical Genetics
American Board of Medical Genetics and Genomics (ABMGG), Clinical Cytogenetics